4
Changes in Ownership
Lycia Therapeutics, Inc. Filed Acc 0001231919-26-001519
10% owner bought 25,004 shares at an average $25.78 ($644,711)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2026-10-28 | Purchase | +10,570 | $25.23 | $266,681 | 6,835,803 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2026-10-28 | Purchase | +4,430 | $25.97 | $115,047 | 6,840,233 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2026-10-29 | Purchase | +1,000 | $26.33 | $26,330 | 6,841,233 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2026-10-30 | Purchase | +8,804 | $26.27 | $231,281 | 6,850,037 | I |
| Venrock Healthcare Capital Partners III, L.P. 10% owner | 2026-10-30 | Purchase | +200 | $26.86 | $5,372 | 6,850,237 | I |
| Open-market purchases · 25,004 sh · avg $25.78 · $644,711 | |||||||
Loading xslF345X06/form4-10302026_111001.xml…